Neoadjuvant endocrine treatment in breast cancer: analysis of daily practice in large cancer center to facilitate decision making-Reference-Cited by-同舟云学术

Neoadjuvant endocrine treatment in breast cancer: analysis of daily practice in large cancer center to facilitate decision making

Published:2014-11 Issue:5 Volume:208 Page:756-763
ISSN:0002-9610
Container-title:The American Journal of Surgery
language:en
Short-container-title:The American Journal of Surgery

Author:

Debled Marc,Auxepaules Gaël,de Lara Christine Tunon,Garbay Delphine,Brouste Véronique,Bussières Emmanuel,Mauriac Louis,MacGrogan Gaëtan

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference22 articles.

1. Neoadjuvant endocrine treatment in primary breast cancer - review of literature;Mathew;Breast,2009

2. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis;Mauri;J Natl Cancer Inst,2005

3. Oestrogen receptor directed primary systemic therapy: a randomised trial compared with conventional therapy in operable breast cancer;Cameron;Breast Cancer Res Treat,2002

4. Estrogen-receptor-directed neoadjuvant therapy for breast cancer: results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy;Gazet;Ann Oncol,2001

5. Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer;Semiglazov;Cancer,2007

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial;ESMO Open;2018

2. Implementing neoadjuvant endocrine strategies in ER-positive, HER2-negative breast cancer;Expert Review of Anticancer Therapy;2017-02-09

3. Neoadjuvant endocrine treatment in early breast cancer: An overlooked alternative?;European Journal of Surgical Oncology (EJSO);2016-03

4. Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer;British Journal of Cancer;2015-07-14

5. One-Year Neoadjuvant Endocrine Therapy in Breast Cancer;Pathology & Oncology Research;2015-03-10